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Background and purpose   Degenerating cartilage releases poten-
tial danger signals that react with Toll-like receptor (TLR) type 
danger receptors. We investigated the presence and regulation of 
TLR1, TLR2, and TLR9 in human chondrocytes. 
Methods   We studied TLR1, TLR2, TLR4, and TLR9 mRNA 
(qRT-PCR) and receptor proteins (by immunostaining) in pri-
mary mature healthy chondrocytes, developing chondrocytes, 
and degenerated chondrocytes in osteoarthritis (OA) tissue sec-
tions of different OARSI grades. Effects of a danger signal and of 
a pro-inflammatory cytokine on TLRs were also studied. 
Results   In primary 2D-chondrocytes, TLR1 and TLR2 were 
strongly expressed. Stimulation of 2D and 3D chondrocytes with 
a TLR1/2-specific danger signal increased expression of TLR1 
mRNA 1.3- to 1.8-fold, TLR2 mRNA 2.6- to 2.8-fold, and TNF-α 
mRNA 4.5- to 9-fold. On the other hand, TNF-α increased TLR1 
mRNA] expression 16-fold, TLR2 mRNA expression 143- to 
201-fold, and TNF-α mRNA expression 131- to 265-fold. TLR4 
and TLR9 mRNA expression was not upregulated. There was a 
correlation between worsening of OA and increased TLR immu-
nostaining in the superficial and middle cartilage zones, while 
chondrocytes assumed a CD166+ progenitor phenotype. Corre-
spondingly, TLR expression was high soon after differentiation 
of mesenchymal stem cells to chondrocytes. With maturation, it 
declined (TLR2, TLR9).
Interpretation   Mature chondrocytes express TLR1 and TLR2 
and may react to cartilage matrix/chondrocyte-derived danger 
signals or degradation products. This leads to synthesis of pro-
inflammatory cytokines, which stimulate further TLR and cyto-
kine expression, establishing a vicious circle. This suggests that 
OA can act as an autoinflammatory disease and links the old 
mechanical wear-and-tear concept with modern biochemical 
views of OA. These findings suggest that the chondrocyte itself is 
the earliest and most important inflammatory cell in OA. 

In vascular tissue, Toll-like receptors (TLRs) have important 
roles in activation of the innate and adaptive host defense 
against infections, by recognizing a specific but restricted 
set of patterns of microbial origin (so-called pathogen- or 
microbe-associated molecular patterns or PAMPs/MAMPs). 
So far, 10 functional TLRs have been identified in humans 
(TLR1–TLR10). TLR2 can form homodimers and heterodi-
mers with TLR1 or TLR6 (Ozinsky et al. 2000), whereas 
the other TLRs form homodimers (Takeda 2005, Lee et al. 
2012). Cell surface TLRs such as TLR1, TRL2, TLR4, and 
TLR6 recognize molecular patterns exposed on the surface 
of microbes to allow immediate ligand-receptor interactions. 
Endosomal TLRs such as TLR3, TLR7, TLR8, and TLR9 rec-
ognize nucleic acids (RNA and/or DNA) exposed first after 
partial degradation of the microbes. TLRs are expressed dif-
ferentially in different tissues and cells (Garrafa et al. 2011), 
which may in part explain some tissue-specific features of the 
host response to our microbiome.
TLRs can also bind to various damage-associated molecu-
lar patterns, which are endogenous danger signals or alarmins 
(Bianchi 2007). This can lead to autoinflammatory condi-
tions, but it also contributes to production of co-stimulatory 
signals necessary for adaptive immune reactions. Chondro-
cyte-derived high-mobility group box 1, heat-shock proteins, 
and several components of the cartilage extracellular matrix 
(ECM)—e.g. low-molecular-weight hyaluronan, heparan sul-
phate, biglycan, and fibronectin fragments—have been identi-
fied as potential TLR ligands (Scanzello et al. 2008, Chang 
2010, Erridge 2010, Hodgkinson and Ye 2011). From this 
point of view, OA could be considered as an autoinflamma-
tory disease with the chondrocyte as its primary inflammatory 
cell, as suggested in a recent editorial (Konttinen et al. 2012).
Reports on chondrocyte TLRs have been quite scarce and 
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(Liu-Bryan et al. 2005, Su et al. 2005, Kim et al. 2006, Liu-
Bryan et al. 2010), whereas TLR1 (Liu-Bryan et al. 2005, Su 
et al. 2005) and TLR9 (Liu-Bryan et al. 2005, Bobacz et al. 
2007) has been claimed to be present or absent. We studied 
these 3 TLRs in the current work. TLRs are differentially 
expressed in human mesenchymal stromal cells (MSCs) 
(Raicevic et al. 2011) and are regulated by inflammatory stim-
uli (Romieu-Mourez et al. 2009). MSC-like progenitors have 
also been described in OA cartilage, although their origin is 
still unclear (Koelling et al. 2009, Pretzel et al. 2011).
We studied the expression of some of the key TLRs men-
tioned above in primary chondrocyte isolates in 2D cultures, 
MSCs in 3D pellets undergoing chondrogenesis, and chon-
drocytes in situ in OA tissue sections representing different 
OARSI (Osteoarthritis Research Society International) grades 
(Pritzker et al. 2006). Their inflammatory regulation in 3D 
pellets was studied using a TLR1/2-specific ligand and tumor 
necrosis factor-α (TNF-α) and compared to different OARSI 
grades of OA. Chondroprogenitor and hematopoietic markers 
were also studied in different grades of OA. 
Patients and methods
Primary chondrocyte isolation and cultures
This study was approved by the local ethical committee (Dnro 
HUS 37/E6/04). After obtaining informed patient consent, pri-
mary chondrocytes were isolated as described earlier (Britt-
berg et al. 1994, 2001) from femoral heads from 4 femoral 
neck fracture arthroplasty patients (see Supplementary mate-
rial). 
hMSC isolation and chondrogenic cultures
Establishment of hMSC lines was approved by the institu-
tional review board. 4 primary MSC lines were established 
from healthy adult donors as described earlier (Supplementary 
material; Sillat et al. 2009). For chondrogenesis experiments, 
passage 3–4 cells were washed twice in chondrogenic induc-
tion medium (Lonza, Basel, Switzerland) using centrifuga-
tion at 150 × g for 5 min and resuspension. Washed cells were 
transferred to medium supplemented with 10 ng/mL TGF-β3 
(R&D Systems, Minneapolis, MN), divided to 2.5 × 105 cells 
per tube, and centrifuged at 150 × g for 5 min. Pellets were 
cultured in polypropylene tubes at 37°C in a humidified atmo-
sphere of 5% CO2 in air. The medium was replaced every 3 
days. Differentiation of the cells in the pellets was studied at 
days 0, 7, 14, and 21.
Stimulation with Pam3CSK4 and TNF-α
Primary chondrocyte isolates (n = 4) and day 21 chondrogenic 
pellets (n = 4) were used for stimulation experiments. Cells 
were placed in regular culture medium and stimulated for 12 
h with 0.5 μg/mL Pam 3CSK4 (Invivogen, San Diego, CA) or 
with 5 ng/mL and 100 ng/mL rhTNF-α (R&D Systems).
Quantitative real-time polymerase chain reaction 
(qRT-PCR)
The mRNA levels of SOX9, COL2A1, TNF-α, TLR1, TLR2, 
TLR4, TLR9, and β-actin were analyzed using qRT-PCR as 
described in Supplementary material.
Immunostaining of TLRs in chondrogenic cultures
Sections of pellets of MSCs induced into chondrogenesis 
were stained for TLR1, TLR2, TLR9, collagen type II, and 
COL2A-3/4M (collagenase-cleaved type II collagen) using 
avidin-biotin-peroxidase complex methods as described in 
Supplementary material.
Safranin O staining and OARSI grading of OA tissue 
samples
This study was approved by the local ethical committee (Dnro 
HUS 165/E6/03). Osteochondral cylinder samples were har-
vested from tibial plateau specimens obtained from knee joints 
of 14 patients (10 female and 4 male), and were stained using 
Safranin T and toluidine blue and graded according to OARSI 
(Pritzker et al. 2006) as described in Supplementary material.
Immunohistochemical staining of different OARSI-
grade OA cartilage tissue sections
Representative samples from all the different OARSI grades 
were stained immunohistochemically for TLR1, TLR2, 
TLR4, and TLR9; TNF-α; CD166 and CD105 (MSC mark-
ers), and CD34 and CD31 (hematopoietic stem cell markers) 
as described in Supplementary material.
Statistics
The qRT-PCR data were analyzed using one-way ANOVA and 
unpaired Student’s t-test. Immunostaining data were analyzed 
using Kruskal one-way variance test to compare the differ-
ences in the proportions of TLR+ or CD166+ cells in differ-
ent OA grades (from 1 to 5) and between different cartilage 
zones (superficial, middle, and deep). Mann-Whitney U-test 
was used for pairwise comparison of TLR-specific differences 
between cartilage zones and different OARSI grades. Wil-
coxon signed rank test was used to compare TLRs between 
the 3 different cartilage zones, separately for each different 
OARSI grade (e.g. grade-1 samples, grade-2 samples etc.). 
Non-parametric tests were used since the data had ordinal 
levels of measurement. We used SPSS software version 18.0 
for Windows. 
Results
TLR1, TLR2, and TLR9 mRNA expression in primary 
chondrocytes
TLR mRNAs were first studied in primary 2D cultures of 
isolated mature hyaline articular cartilage chondrocytes from 
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of TLR1 and TLR2 mRNA compared to TLR9 mRNA levels 
(Figure 1A).
TLR1, TLR2, and TLR9 expression during chondro-
genesis
As even in trauma patients the primary chondrocytes may 
already have been exposed to inflammatory cytokines, we 
In order to determine whether TLR1 and 2 receptors are func-
tional, the cells were stimulated with the synthetic TLR1/2 
ligand Pam3CSK4. In 2D cultured primary chondrocytes (n = 
4) and day-21 3D chondrogenic chondrocyte pellets (n = 4), 
the TLR1/2 ligand caused a 4.5-fold (p = 0.06) and a 9.0-fold 
(p = 0.03) increase in TNF-α mRNA, respectively (Figure 3). 
Correspondingly, TLR1 mRNA expression increased 1.3-fold 
Figure 1. A. Toll-like receptors TLR1, TLR2, and TLR9 in 4 primary chondrocyte iso-
lates. B–D. 4 mesenchymal stem cell lines (day 0) differentiating via a progenitor 
stage (days 7 and 14) to chondrocytes (day 21). Quantitative real-time polymerase 
chain reaction was used to measure the mRNA copy numbers per 106 β-actin copies. 
In primary chondrocyte isolates, TLR1 and TLR2 mRNA levels were higher than 
TLR9 mRNA levels († p < 0.001). Overall changes in TLR2 and TLR9 mRNA expres-
sion were significant during chondrogenesis.
wanted to monitor TLR mRNA expression in 
de novo generated chondrocytes and to follow 
how this changed during differentiation. TLR1 
mRNA increased slightly from MSCs to day 7 
chondrocyte progenitors, but declined thereafter 
(p = 0.6) (Figure 1B). TLR2 mRNA increased 
11.4-fold from day 0 (MSCs) to day 7 (chondro-
cyte progenitors) and then progressively declined 
at days 14 and 21 (p < 0.001) (Figure 1C). TLR9 
mRNA was highest in day 0 MSCs and then pro-
gressively diminished (p = 0.004) (Figure 1D). 
After 21 days of differentiation, the pellets 
from all 4 patients showed an increase in the 
expression of chondrogenic markers with a mean 
9-fold (SD 7) increase in Sox9 mRNA expres-
sion and a 571-fold (SD 922) increase in Col2A1 
mRNA expression relative to the controls (hMSC 
pellets kept for 21 days in regular medium). Dif-
ferentiated day 21 pellets also stained positively 
for collagen type II and proteoglycans (Figure 
2E, F). Chondrocytes in the 3D-pellets stained 
for TLR1 (Figure 2A) and TLR2 (Figure 2B), but 
not for TLR9 (Figure 2C).
TLR1/2-specific stimulation of chondro-
cytes
Figure 2. Chondrocyte pellets at day 21 produced from human bone marrow-derived mesenchymal stem cells. A–D. Immunostaining of TLR1 
(panel A), TLR2 (panel B), and TLR9 (panel C) compared to negative staining control (panel D). Magnification 200×. E–G. Collagen type-II 
immunostaining (Collagen II, panel E) and Safranin O staining of untreated 3D chondrocyte pellets (control, panel F) compared to pellets treated 



























588 Acta Orthopaedica 2013; 84 (6): 585–592
(p = 0.03) and 1.8-fold (p = 0.2). TLR2 mRNA increased 2.8-
fold (p = 0.03) and 2.6-fold (p = 0.05). In comparison, the 
expression levels of TLR4 and TLR9 mRNA remained stable, 
with TLR4 showing 1.0-fold (p = 0.4) and 0.9-fold (p = 0.4) 
differences and TLR9 showing 1.1-fold (p = 0.8) and 1.0-fold 
(p = 0.9) differences.
(data not shown).
In grade-1 OA samples, TLR1+ chondrocytes were con-
fined to the surface zone. With increasing degeneration, 
TLR1 immunostaining became more intense, the proportion 
of TLR1+ chondrocytes increased in the surface zone, and 
TLR1+ cells also appeared in the middle and even in the deep 
Figure 3. Folds of change in tumor necrosis factor-α (TNF-α) expression and 
TLR1, TLR2, TLR4, and TLR9 expression upon stimulation with TLR 1/2-specific 
ligand Pam 3CSK4. Primary 2D chondrocyte cultures (A) and 3D chondrocyte 
pellet cultures (B) at day 21 (i.e. produced from human mesenchymal stem cells 
at day 21). † p ≤ 0.05 compared to unstimulated cultures. 
TNF-α stimulation of chondrocytes
Due to the substantial increase in TNF-α mRNA 
expression from TLR1/2-mediated danger signal 
stimulation, we also studied the effects of TNF-α on 
TLRs. Day-21 3D chondrogenic chondrocyte pellets 
(n = 4) stimulated with 5 ng/mL rhTNF-α caused a 
130.6-fold increase in TNF-α mRNA (p = 0.049), a 
16-fold increase in TLR1 mRNA (p = 0.1), a 143-
fold increase in TLR2 mRNA (p = 0.04) and only 
a 2.6-fold increase in TLR4 mRNA (p = 0.1) and a 
3.2-fold increase in TLR9 mRNA (p = 0.3) compared 
to pellets cultured in the absence of rhTNF-α (Figure 
4). A TNF-α dose of 100 ng/mL increased the TNF-α 
mRNA expression 265-fold (p = 0.04), TLR1 mRNA 
expression 16-fold (p = 0.1), TLR2 mRNA 201-fold 
(p = 0.06), TLR4 mRNA 3.6-fold (p = 0.2) and TLR9 
mRNA expression 2.2-fold (p = 0.2) compared to 
unstimulated cultures (Figure 4).
TNF-α used at 0, 5, and 100 ng/mL also caused 
a dose-dependent loss of proteoglycans in day-21 
chondrocyte pellets (Figure 2F–H). Immunostaining 
of day-21 3D chondrogenic chondrocyte pellets for 
collagenase-cleaved COL2A-3/4M neoepitope was 
increased with TNF-α stimulation, but was more 
intense after treatment with 5 ng/mL than 100 ng/
mL TNF-α (Figure 5C and D). Immunostaining of 
collagenase-cleaved COL2A-3/4M neoepitope was 
seen in chondrocytes and ECM. Immunostaining of 
unstimulated day-21 3D chondrogenic chondrocyte 
pellets with collagenase-cleaved COL2A-3/4M neo-
epitope was weak (Figure 5A). 
Chondrocyte progenitor markers and TLRs in 
different OARSI-grade OA samples
Chondroprogenitor cells have been reported to be 
present in healthy human articular cartilage and in 
late OA cartilage (Koelling et al. 2009, Pretzel et al. 
2011). However, the possible relationship between 
progenitor markers and OA grade has not been 
studied before. The MSC marker CD105 was only 
slightly increased in the higher OARSI-grade OA 
samples (the proportion of positive cells remaining 
was always < 20%; data not shown). In contrast, the 
proportion of CD166+ cells increased with increas-
ing OARSI grade in the surface and middle zones 
(p = 0.005 and p = 0.001) (Table and Supplementary 
figure). All cells in the cartilage were negative for 
hematopoietic cell lineage markers CD31 and CD34 
Figure 4. Folds of change in tumor necrosis factor-α (TNF-α), TLR1, TLR2, TLR4, 
and TLR9 upon stimulation of primary 3D chondrocyte pellet cultures. Stimulation 
with 5 ng/mL TNF-α (A) and with 100 ng/mL TNF-α (B). † p ≤ 0.05. All statistical 
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zone. In OARSI grade-3 and -4 OA samples, some TLR1-
specific staining was also seen in the ECM (Figure 6, lower 
row). A similar specific staining pattern was seen for TLR2 
and TLR9 (see Supplementary figure).
All TLRs showed a similar pattern in histomorphometry 
(Table; TLR9 data not shown). The proportion of positively 
stained cells increased in the surface and middle zones with 
progression of OA to grades 3 and 4 (p < 0.01 except for TLR2 
in the surface zone: p = 0.01). In grade-5 OA samples, the 
surface zone was totally worn off and the percentage values 
of TLR+ chondrocytes in the remaining middle zone were low 
(Table).
Discussion
Cartilage is subjected to considerable mechanical impact, 
compression, tensile and shear loading. Due to the lack of 
blood vessels, lymphatic vessels, and nerves, hyaline articular 
cartilage has a poor capacity for repair (van Osch et al. 2009). 
Figure 5. Collagenase-cleaved COL2A-3/4M neoepitope immunos-
taining of 3D chondrocyte pellets. Untreated 3D-chondrocyte pellets 
(A) and the negative staining control (B). 3D chondrocyte pellets stimu-
lated with 5 ng/mL TNF-α (C) and 100 ng/mL TNF-α (D). Magnification 
100×.
Figure 6. Safranin O, TLR1, and TNF-α staining of OARSI-graded osteoarthritis samples 
(grades G1–G5). TLR2 and TLR9 immunostaining was rather similar to that of TLR1 and 
is shown in Supplementary figure. Surface (tangential, gliding), middle (transient), and 
deep (radial) zones are marked, and also tide mark (between cartilage and calcified car-
tilage) and subchondral bone. The safranin O microphotographs are panoramic images, 
constructed from several microphotographs to provide an overall view of all zones in one 
image. Magnification 100×.
Cartilage cannot readily recruit circulat-
ing MSCs, but is dependent on the repair 
capacity of the sessile mature chondro-
cytes and chondrocyte progenitors (Koel-
ling et al. 2009, Grogan et al. 2009). The 
lack of a convective transit compartment 
(i.e. vessels) means that repair is confined 
to the pericellular and the nearby intrater-
ritorial cartilage matrix area. As the car-
tilage degenerates, matrix molecules are 
released—perhaps in partially degraded 
and denatured form—and can act as danger 
signals that bind to danger signal receptors 
(Erridge et al. 2010). The present study 
shows conclusively that non-OA chondro-
cytes and chondrocytes generated from 
MSCs express TLR1, TLR2, and somewhat 
less TLR9, at the mRNA and/or protein 
level. Our findings also suggest that the TLR 
profile is highly dependent on the activation 
and differentiation state of the chondroid 
cells, with for example TLR9 being mainly 
present in inflamed (OA) chondrocytes and 
progenitors, but being scanty in mature, 
resting chondrocytes. This may explain the 
apparent discrepancies mentioned in the 
Introduction (Liu-Bryan et al. 2005, Su et 
al. 2005, Bobacz et al. 2007).
Given the lack of blood and lymphatic 
vessels, endogenous cartilage matrix-
derived danger signals (alarmins) are not 
washed away from the cartilage (Heinegård 
and Saxne 2011). The undiluted danger 
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tions in chondrocyte lacunae. Chondrocytes in lacunae are 
equipped with danger signal receptors of TLR-type and can 
be stimulated by locally produced matrix-derived TLR ligands 
(for a table of endogenous danger signals, see Konttinen et 
al. 2012). TLR profiling of the cartilage revealed TLR1 and 
TLR2, which can also form TLR1/2 heterodimers (Ozinsky 
et al. 2000). Because these are the prominent chondrocyte 
TLRs, we used Pam3CSK4 for stimulation of 2D primary 
chondrocytes and 3D chondrocyte pellets. These experiments 
disclosed 2 interesting things. First, they confirmed the pres-
ence of TLR1 and TLR2 on human chondrocytes, by show-
ing that the TLR1/2 receptor is also functionally active. More 
importantly, danger signal-TLR1/2 interaction led to a sub-
stantial production of pro-inflammatory TNF-α. At the same 
time, danger signal-TLR1/2 interaction led to a more or less 
significant upregulation of TLR1 and TLR2 mRNA, without 
affecting TLR9. These findings suggest that TLRs in chondro-
cytes are actively engaged and differentially regulated in the 
inflammatory process.
Due to a substantial increase in TNF-α by danger signal 
stimulation of TLR1/2, its effects on chondrocytes could be 
studied. Again, we made 2 interesting observations. TNF-α 
treatment increased TLR1 and TLR2 mRNA expression more 
or less significantly, which could increase TLR1/2 recep-
tor expression. Although TLR2 mRNA expression increased 
much more than TLR1 mRNA expression, the starting values 
for TLR1 mRNA were higher than those for TLR2 mRNA. 
Furthermore, TLR2 also forms TLR2/2 homodimers and 
TLR2/TLR6 heterodimers (Ozinsky et al. 2000), which may 
consume surplus TLR2. Secondly, at physiological and sup-
raphysiological concentrations, TNF-α increased its own pro-
duction in chondrocytes 131- to 264-fold in a dose-dependent 
manner. A possible self-amplifying loop emerges: danger 
signal stimulation upregulates TNF-α and TLR1/2 expres-
sion, and conversely TNF-α upregulates TLR1/2 expression 
and also its own production. One of the key conclusions of 
our work is that chondrocytes might be involved already at the 
early stages of OA.
TNF-α-stimulation caused dose-dependent proteoglycan 
depletion. In line with this result, COL2A-3/4M immunostain-
ing showed an increase in type-II collagen in 3D chondrocyte 
pellets stimulated with TNF-α. Such a pattern seems to be in 
agreement with other studies that have demonstrated a corre-
lation between aggrecan and collagen degradation (Squires et 
al. 2003). These results show that chondrocytes can mount an 
inflammatory response, which might be sufficient to compro-
mise the integrity of native proteoglycans and collagen ECM.
We then studied the expression of TLR1, TLR2, TLR4, and 
TLR9 by chondrocytes in OA samples, using the histologi-
cal OARSI grading as the reference of disease severity. TLR1, 
TLR2, and TLR4—but also TLR9—increased with progres-
sion of OA until grade 3–4, but then all TLRs declined so that 
a bell-shaped curve emerged. Upregulation of TLRs was first 
seen in the surface zone and later in the middle zone, and even 
in the deep zone. Earlier studies have emphasized the role of 
TLR4 in osteoarthritis, but our results show that TLRs other 
than TLR4 also become upregulated in OA and may partici-
pate in OA pathogenesis. 
The present work shows for the first time that with increas-
ing severity of OA, the proportion of cells positive for the 
progenitor/stem cell marker CD166 (Lee et al. 2009, Pretzel 
et al. 2011) also increases. With progressive OA, the chon-
drocytes appear to assume a more immature phenotype. We 
therefore decided to study the reverse process and determine 
how the TLR phenotype of the progenitor cells changes during 
chondrogenesis. The TLR profile was dependent on the devel-
opmental stage of the differentiating cells, with TLRs being 
lower in the differentiated cells than in the day-14 intermedi-
ate and day-7 early progenitors. Thus, inflammatory chondro-
cytes in severe OA show a more embryonic, progenitor TLR 
phenotype than chondrocytes in mild OA (Lee et al. 2009). 
This is in accordance with reports describing chondrocyte pro-
Histomorphometric evaluation of progenitor cell marker CD166 and Toll-like receptors 1 (TLR1), 2 (TLR2), and 4 (TLR4) in OARSI-graded 
grade 1–5 osteoarthritis (OA) samples. Proportions of positively stained cells (%) in the surface (S), middle (M), and deep zones (D) are 
given. Because the surface zone was totally worn off in all G5 OA samples, no value is given for this zone in grade-5 OA samples. Mean 
and SD
 G1 G2 G3 G4 G5
 S M D S M D S M D S M D S M D
CD 166 51 0 0 81 0 0 85 46 0 97 72 0 – 35 0
 (17)   (7)   (8) (19)  (6) (8)   (6)
TLR 1 24 0 0 82 22 0 96 64 14 96 74 0 –  16 0
 (1)   (12) (6)  (4) (7) (2) (7) (8)   (6) 
TLR 2 30 5 2 80 23 2 96 48 12 96 60 0 – 14 0
 (6) (3) (0) (12) (7) (3) (4) (14) (11) (6) (5)   (10) 
TLR4 24 4 0 94 44 6 95 59 0 97 45 0 – 29 0
 (5) (4)  (6) (8) (3) (6) (12)  (5) (8)   (23) 
TLR9 44 7 0 98 38 24 96 61 0 87 34 0 – 23 0
 (6) (13)  (2) (27) (5) (5) (11)  (7) (13)   (10)
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genitors in OA (Alsalameh et al. 2004, Grogan et al. 2009, 
Koelling et al. 2009, Pretzel et al. 2011), bioinformatics analy-
sis of OA (Pitsillides and Beier 2011), and the present obser-
vations on TLRs.
We found that TLR1 and TLR2 are expressed during chon-
drogenesis, in mature primary chondrocytes, and in degener-
ated chondrocytes in OA. Therefore, if cartilage degeneration 
in OA leads to a release of matrix-derived danger signals, 
they might be recognized by the TLRs of the close-by chon-
drocytes. The expression of TLR1, TLR2, TLR4, and TLR9 
increased with the severity of the disease until grade 3–4, sug-
gesting that danger signals and inflammatory cytokines may 
regulate chondrocyte TLRs in OA. This work suggests that 
OA might act as an autoinflammatory disease and links the old 
mechanical wear-and-tear concept with a modern paradigm of 
OA as a biochemically-mediated autoinflammatory condition.
In this work, we studied only the effect of TNF-α on chon-
drocytes. Although it seemed to regulate TLR2 mRNA expres-
sion and (somewhat less) TLR1 mRNA expression, TLR4 and 
TLR9 mRNA expression levels were not affected. This sug-
gests that in the upregulation of TLR4 and TLR9, other inflam-
matory cytokines and danger signals probably have more 
important roles. Indeed, TLR4 expression has been shown 
to be upregulated by IL-1β (Campo et al. 2012), by alarmins 
such as S100A8 and S100A9 (Schelbergen et al. 2012), and 
by low-molecular-weight hyaluronan (Campo et al. 2010). On 
the other hand, stimulation with TLR4 ligands has been shown 
to increase IL-1β expression in chondrocytes (Bobacz et al. 
2007). It may therefore be that different cytokines play dif-
ferent roles in upregulation of various TLRs and their positive 
feedback loops. Thus, further studies are necessary to deter-
mine the exact roles of different cytokines and danger signals 
in modulating the expression levels of individual TLRs during 
the pathogenesis of OA.
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Supplementary figure and methods are available at Acta’s 
website (www.actaorthop.org), identification number 6158.
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